DBV Technologies | Spese Operative



Operating Expenses Cambiamento Data
Acadia Pharmaceuticals USD 225.03M 118.93M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amarin USD 67.47M 549K 2024-09
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
DBV Technologies USD 31.4M 3.6M 2024-09
Halozyme Therapeutics USD 123.33M 819K 2025-03
Incyte USD 847.73M 29.46M 2025-03
Insmed USD 334.86M 28M 2024-12
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
PTC Therapeutics USD 205.87M 69.79M 2025-03
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Ultragenyx Pharmaceutical USD 282.23M 4.92M 2025-03
United Therapeutics USD 411.6M 33.4M 2025-03



DBV Technologies Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.